SCHEMBL21653190

SCHEMBL21653190

CCn1cc(NC(=O)c2cccc(Cl)c2)ccc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.54
▸ KCNK3 O14649 2/20 0.52
▸ KCNK9 Q9NPC2 2/20 0.52
▸ RXFP1 Q9HBX9 1/20 0.52
▸ RAB9A P51151 6/20 0.51
▸ NPC1 O15118 5/20 0.51
▸ KCNQ3 O43525 2/20 0.51
▸ KCNQ2 O43526 2/20 0.51
▸ KCNE1 P15382 2/20 0.51
▸ KCNQ1 P51787 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ KCNQ5 Q9NR82 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21653177 0.88 MAPT (0.46) ALDH1A1RXFP1RAB9ANPC1MAPT
SCHEMBL21653182 0.84 KMT2A (0.52) RAB9ANPC1KCNQ3KCNQ2KCNE1
SCHEMBL21653176 0.84 MEN1 (0.58) RAB9ANPC1KCNQ3KCNQ2KCNE1
SCHEMBL21653184 0.83 KCNQ3 (0.53) RAB9ANPC1KCNQ3KCNQ2KCNE1
SCHEMBL21653193 0.81 KCNQ3 (0.53) RAB9ANPC1KCNQ3KCNQ2KCNE1
SCHEMBL21653246 0.80 MAPT (0.43) ALDH1A1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL21652920 0.79 MAPT (0.42) RAB9ANPC1MAPTTP53MEN1
SCHEMBL21653070 0.78 MEN1 (0.44) ALDH1A1RXFP1RAB9ANPC1MAPT
SCHEMBL28708129 0.78 KCNK3 (0.59) ALDH1A1KCNK3KCNK9RXFP1RAB9A
SCHEMBL29389710 0.78 KCNK3 (0.59) ALDH1A1KCNK3KCNK9RXFP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023657-A1 PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS Epizyme, Inc. (US) 2020-01-30 — — WO disclosed
Send feedback